ACCENTMICST Stock Price Today (NSE: ACCENTMIC)
Fundamental Score
ACCENTMICST Share Price Live NSE/BSE & Institutional Fundamental Analysis
ACCENTMICST share price today is ₹344.35, up +0.00% on NSE/BSE as of 2 January 2026. ACCENTMICST (ACCENTMIC) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹826.06 (Cr). The 52-week high for ACCENTMIC share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 23.83x, ACCENTMIC is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 18.44% and a debt-to-equity ratio of 0.00.
ACCENTMICST Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
ACCENTMICST Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
ACCENTMICST Share Price: A Conservative Value Investor's Perspective
Within the pharmaceutical sector, pricing pressures and stringent regulatory oversight are constant realities, creating a challenging landscape for sustained profitability. This analysis examines the financial health of ACCENTMICST, specifically focusing on a capital safety perspective and the current ACCENTMICST share price of ₹344.35. The primary objective is to assess the company's resilience based on key financial metrics, drawing from a fundamental audit verified by Sweta Mishra.
ACCENTMICST currently trades at a Price-to-Earnings (PE) ratio of 23.83. To gauge the relative valuation, it's important to compare this to its peers. For instance,
Mankind Pharma Ltd often commands a premium valuation potentially reflecting market perception of superior management quality and brand strength. While ACCENTMICST's PE ratio suggests a potentially fair valuation relative to current earnings, a deeper dive into management effectiveness and capital allocation decisions is warranted for a conservative investor seeking a margin of safety. Furthermore, it's important to acknowledge that peers like Smruthi Organics Ltd and Balaxi Pharmaceuticals Ltd may operate in niche areas, requiring detailed understanding before direct comparison.A crucial element in assessing ACCENTMICST's long-term viability is its Return on Capital Employed (ROCE) of 23.66%. This strong ROCE suggests that ACCENTMICST is efficiently deploying capital to generate profits. Over time, a consistent and high ROCE can contribute significantly to the strengthening of the company's economic moat, potentially shielding it from competitive pressures and enabling sustained profitability. However, it is crucial to investigate if this ROCE is sustainable and driven by genuine competitive advantages, rather than short-term factors.
This analysis forms a small part of a larger, 80-parameter fundamental audit of ACCENTMICST. The audit considers a wide range of factors, including debt levels, cash flow generation, and competitive positioning within the pharmaceutical industry. Therefore, this initial assessment only provides a snapshot of the company's financial standing, and should not be construed as investment advice. A comprehensive understanding is crucial before making informed decisions. This observation has been verified by Sweta Mishra.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
ACCENTMICST Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ACCENTMIC across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Return on Equity (18.44%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (23.66%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 23.83 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Consistent Growth Track Record (15.05% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (51.23% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (87.29x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (55.44%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
Limited Institutional Interest (FII+DII: 3.29%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
ACCENTMICST Financial Statements
Comprehensive financial data for ACCENTMICST including income statement, balance sheet and cash flow
About ACCENTMIC (ACCENTMICST)
ACCENTMICST (ACCENTMIC) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a current market capitalisation of ₹826.06 (Cr). ACCENTMICST has delivered a Return on Equity (ROE) of 18.44% and a ROCE of 23.66%. The debt-to-equity ratio stands at 0.00, reflecting the company's capital structure. Investors tracking ACCENTMIC share price can monitor key metrics including P/E ratio, promoter holding of 55.44%, and quarterly earnings growth.
Company Details
ACCENTMIC Share Price: Frequently Asked Questions
What is the current share price of ACCENTMICST (ACCENTMIC)?
As of 02 Jan 2026, 05:21 pm IST, ACCENTMICST share price is ₹344.35. The ACCENTMIC stock has a market capitalisation of ₹826.06 (Cr) on NSE/BSE.
Is ACCENTMIC share price Overvalued or Undervalued?
ACCENTMIC share price is currently trading at a P/E ratio of 23.83x, compared to the industry average of 31.77x. Based on this relative valuation, the ACCENTMICST stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of ACCENTMIC share price?
The 52-week high of ACCENTMIC share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the ACCENTMICST share price?
Key factors influencing ACCENTMIC share price include quarterly earnings growth (Sales Growth: 10.58%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is ACCENTMICST a good stock for long-term investment?
ACCENTMICST shows a 5-year Profit Growth of 51.23% and an ROE of 18.44%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing in ACCENTMIC shares.
How does ACCENTMICST compare with its industry peers?
ACCENTMICST competes with major peers in the Pharmaceuticals. Investors should compare ACCENTMIC share price P/E of 23.83x and ROE of 18.44% against the industry averages to determine competitive standing.
What is the P/E ratio of ACCENTMIC and what does it mean?
ACCENTMIC share price has a P/E ratio of 23.83x compared to the industry average of 31.77x. Investors pay ₹24 for every ₹1 of annual earnings.
How is ACCENTMIC performing according to Bull Run's analysis?
ACCENTMIC has a Bull Run fundamental score of 60/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does ACCENTMIC belong to?
ACCENTMIC operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting ACCENTMICST share price.
What is Return on Equity (ROE) and why is it important for ACCENTMIC?
ACCENTMIC has an ROE of 18.44%, which indicates excellent management efficiency. ROE measures how efficiently ACCENTMICST generates profits from shareholders capital.
How is ACCENTMIC debt-to-equity ratio and what does it indicate?
ACCENTMIC has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk.
What is ACCENTMIC dividend yield and is it a good dividend stock?
ACCENTMIC offers a dividend yield of 0.29%, meaning you receive ₹0.29 annual dividend for every ₹100 invested in ACCENTMICST shares.
How has ACCENTMIC share price grown over the past 5 years?
ACCENTMIC has achieved 5-year growth rates of: Sales Growth 15.05%, Profit Growth 51.23%, and EPS Growth 10.06%.
What is the promoter holding in ACCENTMIC and why does it matter?
Promoters hold 55.44% of ACCENTMIC shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in ACCENTMICST.
What is ACCENTMIC market capitalisation category?
ACCENTMIC has a market capitalisation of ₹826 crores, placing it in the Small-cap category.
How volatile is ACCENTMIC stock?
ACCENTMIC has a beta of N/A. A beta > 1 suggests the ACCENTMICST stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is ACCENTMIC operating profit margin trend?
ACCENTMIC has a 5-year average Operating Profit Margin (OPM) of 12.36%, indicating the company's operational efficiency.
How is ACCENTMIC quarterly performance?
Recent quarterly performance shows ACCENTMICST YoY Sales Growth of 10.58% and YoY Profit Growth of 9.71%.
What is the institutional holding pattern in ACCENTMIC?
ACCENTMIC has FII holding of 0.00% and DII holding of 3.29%. Significant institutional holding often suggests professional confidence in the ACCENTMICST stock.